Achilles Therapeutics (NASDAQ:ACHL) ADRs added ~42% in the premarket on Thursday after the U.K.-based biotech announced plans ...

Following the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials, the Company has ...

Employees at Achilles Therapeutics are bracing themselves ... therapy programme and shutting down the phase 1/2a CHIRON and THETIS clinical trials. In a statement, chief executive Iraj Ali said ...

000lb It was named after Achilles of Greek legend The story goes that Achilles was dipped by his mother Thetis in the River Styx, to make him invincible But she held him by his heel which remained ...

Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 - LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics ...